Industry

Community Practice Innovation Award to Help Advance Patient Care and Improve Patient Health ATLANTA–(BUSINESS WIRE)–The Rheumatology Research Foundation today announced the launch of a new grant, the Community Practice Innovation (CPI) Award. The grants will empower rheumatology practitioners to generate new research that advances patient care and improves the health of those living with rheumatic … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Bamboo Health™, formerly Appriss Health and PatientPing, a healthcare technology solutions company focused on fostering care collaboration and providing information and actionable insights across the entire continuum of care today announced its expanded partnership with the Iowa Board of Pharmacy to offer Prescription Monitoring Program (PMP) integration within Iowa providers’ electronic health record … [Read more…]

Digital therapeutic delivers gold-standard treatment for nonspecific back pain, improves function and quality of life outcomes. Kaia Health users experienced pain reduction of 1.85 points after only 3 months Cost-effectiveness analysis shows a reduction in healthcare costs of up to 80% versus traditional care Federal Joint Committee (G-BA),3 has recommended applying the approach of Rise-uP … [Read more…]

MADISON, Wis.–(BUSINESS WIRE)–Navitus Health Solutions, an industry-disrupting pharmacy benefit manager (PBM) that’s committed to bringing humanity to pharmacy benefits management through greater transparency and affordability, announced today that it has been selected as a partner by the Health Transformation Alliance (HTA) to provide best-in-class PBM services for its members. Through this partnership, Navitus will offer … [Read more…]

SEOUL, South Korea–(BUSINESS WIRE)–ImmunAbs Inc. (www.immunabs.com) announced that it has received US FDA approval for a Phase 1 clinical trial and that it is now ready to initiate a phase 1 clinical trial in the United States. ImmunAbs is developing IM-101, a monoclonal antibody targeting complements that play essential roles in the immune system but, … [Read more…]

SEOUL, South Korea & CAMBRIDGE, Mass.–(BUSINESS WIRE)–#Gout–LG Chem recently announced that the Company has submitted an IND application to the US FDA for its first independent global Phase 3 clinical trial of its new gout drug ‘Tigulixostat’ (clinical program name: EURELIA_1 Study). LG Chem’s strategy is to expand its life sciences business and to reach … [Read more…]

NEW ‘Transparency Talks’ With Pfizer and Global Pricing Innovations (GPI) Help Pharmaceutical Companies Stay Compliant With Drug Pricing SAN MATEO, Calif.–(BUSINESS WIRE)–#LifeSciences—Model N, Inc. (NYSE: MODN), the leader in revenue optimization and compliance, today announced the launch of Transparency Talks, a new, three-part education series for pharmaceutical companies that tackles the topic of price transparency … [Read more…]

SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (OTCQB: KNWN) an emerging developer of non-invasive medical diagnostic technology, today announced it has filed a Form S-1 registration statement for a proposed new offering of 3 million shares of its common stock with an anticipated offering price of $2.00 per share. Concurrent with, and as a condition to, the offering, … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–Texas Original, Texas’ leading medical cannabis provider, announced that Kelly Roland has been promoted to president. Roland served as Texas Original’s senior vice president of sales and chief revenue officer for three years. During that time, she oversaw and drove the company’s rise to its commanding leadership position in Texas’ growing cannabis market. … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) today announced that the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) will reconvene to review the New Drug Application (NDA) for AMX0035 (sodium phenylbutyrate and taurursodiol [also known as ursodoxicoltaurine]) for the treatment of amyotrophic lateral sclerosis (ALS). The second … [Read more…]